Jafron Biomedical Co.,Ltd. (SHE:300529)
China · Delayed Price · Currency is CNY 19.69
+0.43 (2.23%)
Nov 13, 2026, 3:04 PM CST
Jafron Biomedical Market Cap
Jafron Biomedical has a market cap or net worth of 15.25 billion as of November 13, 2026. It is the 6,092nd most valuable company in the world and the 1,069th biggest in China. Its market cap has decreased by 5.34% in one year.
Market Cap
15.25B
Enterprise Value
13.71B
Revenue
2.07B
Global Rank
Country Rank
#1,069 China
PE Ratio
23.43
ChartMarket Cap Chart
Since August 2, 2016, Jafron Biomedical's market cap has increased from 6.41B to 15.25B, an increase of 137.99%. That is a compound annual growth rate of 8.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 15.25B | 0.10% |
| Dec 31, 2025 | 15.23B | -32.96% |
| Dec 31, 2024 | 22.72B | 27.96% |
| Dec 29, 2023 | 17.76B | -28.23% |
| Dec 30, 2022 | 24.74B | -42.00% |
| Dec 31, 2021 | 42.65B | -21.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lepu Medical Technology (Beijing) | 22.43B |
| Autobio Diagnostics | 21.84B |
| Double Medical Technology | 16.34B |
| Shandong Weigao Blood Purification Products | 14.39B |
| MeHow Innovative | 13.76B |
| Insight Lifetech | 11.68B |
| Shanghai MicroPort Endovascular MedTech | 10.31B |
| Cofoe Medical Technology | 10.30B |